Is Linalool safe in cosmetics?
Linalool has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted. 1 toxicological study endpoint(s) are available in our database.
Also known as: 3,7-Dimethyl-1,6-octadien-3-ol, 3,7-Dimethyl-3-hydroxy-1,6-octadiene, 3,7-Dimethyl-3-ol-1,6-octadiene, Phantol, 1,6-octadien-3-ol, 3,7-dimetil - (+14 more)
INCI: LINALOOL
Linalool (CAS 78-70-6) is a cosmetic fragrance functioning as fragrance; skin-conditioning. NOAEL 117 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max Mandatory individual label declaration above 10 ppm in leave-on products, 100 ppm in rinse-off products (EU 26 allergen list). IFRA 51st Amendment imposes stricter limits on linalool hydroperoxide content in formulations.. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Linalool.
Calculate MoS for your specific formulation with the MoS Calculator.
1 study endpoint found for Linalool. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | 1000 mg/kg bw/day | oral | rat | Developmental | COSMOS DB |
Globally Harmonized System classification per ECHA C&L inventory and ILO/WHO International Chemical Safety Cards.
Pre-calculated NOAEL → SED → MoS audit trail for Linalool across SCCS product categories, with measured dermal absorption where available.
Contact sensitization data for Linalool based on clinical patch test studies and IFRA standards.
Source: ESSCA/NACDG
Skin absorption and penetration characteristics of Linalool, relevant to systemic exposure and MoS calculations.
Source: SCCS Opinion
9 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| LEL | =300 mg/kg-day | Chicken | oral | subchronic | EFSA |
| LEL | =300 mg/kg-day | Pig | oral | subchronic | EFSA |
| LEL | =300 mg/kg-day | Cow Family | oral | subchronic | EFSA |
| NOAEL | =117 mg/kg-day | Rat | oral | short-term | EFSA |
| NOAEL | =160 mg/kg-day | Rat | oral | short-term | HESS |
| LD50 | =3000 mg/kg | Mouse | oral | - | ChemIDplus |
| LD50 | =5610 mg/kg | Rabbit | dermal | - | ChemIDplus |
| LD50 | =2790 mg/kg | Rat | oral | - | ChemIDplus |
| LD50 | =5610 mg/kg | Rat | dermal | - | ChemIDplus |
Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.
Source: LLNA: Gerberick et al. (2005) | Report to RIFM by DSM Nutritional Products (RIFM DB #71508); DPRA: Nukada et al. 2013 [DOI:10.1016/j.tiv.2012.11.006] | Natsch et al. 2013 [DOI:10.1002/jat.2868]; KS: Natsch et al. 2013 [DOI:10.1002/jat.2868]; hCLAT: Ashikaga et al. 2010 [DOI:10.1177/026119291003800403]; HPPT: [103] Greif N (1967): Cutaneous safety of fragrance material as measured by the maximization test.
5 human repeat insult patch tests aggregated from dermatological literature.
| Test Type | N | Sensitized | Dose µg/cm² | NESIL µg/cm² | Potency |
|---|---|---|---|---|---|
| HRIPT | 119 | 0 | 14999 | 14999 | non-sensitizer |
| HRIPT | - | 0 | 14999 | 14999 | non-sensitizer |
| HMT | - | 0 | 4965.52 | - | - |
| HMT | - | 0 | 5184 | - | - |
| HMT | - | 0 | 12960 | - | - |
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
weak modulator
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| AU | restricted | - | fragrances |
| GCC | restricted | 0.001 | Leave-on products |
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
| Type | DA % | Method | Skin Model | SCCS Ref |
|---|---|---|---|---|
| measured_in_vitro | 1.84-14.7 | In vitro; human epidermal membranes; various vehicles | Human epidermal membranes | Int J Pharm 2022; Lalko et al. (RIFM) (2022) |
International Fragrance Association standards per product category. Restriction: Specification. Effective: 2004-01-01.
| Category | Max % | Category | Max % |
|---|---|---|---|
| 1 (Lip products) | – | 7a (Deodorant – not spray) | – |
| 2 (Body spray) | – | 7b (Deodorant spray) | – |
| 3 (Body cream) | – | 8 (Face cream) | – |
| 4 (Fine fragrance) | – | 9 (Soap) | – |
| 5a (Body lotion) | – | 10a (Household – non-spray) | – |
| 5b (Face cream leave-on) | – | 10b (Household – spray) | – |
| 5c (Hand cream) | – | 11a (Intimate – leave-on) | – |
| 5d (Baby cream) | – | 11b (Intimate – rinse) | – |
| 6 (Mouthwash) | – | 12 (Not for consumer exposure) | – |
Reported concentration ranges per product category from SCCS/CIR/industry sources.
| Product Category | Typical Range | Max Reported | Source |
|---|---|---|---|
| Face Cream | 0.001–0.5 | 2 | CIR Safety Assessment |
Preliminary editorial summary for Linalool — not a computed safety verdict. See the sourced toxicological data above.
Public NOAEL study rows linked to Linalool by CAS number or substance name.
| Absorption % | Method | Vehicle |
|---|---|---|
| 1.84-14.7 | In vitro; human epidermal membranes; various vehicles | EtOH/water, DPG, DEP, petrolatum, mixed |
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Linalool has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted. 1 toxicological study endpoint(s) are available in our database.
Linalool EU regulatory status: restricted. Maximum allowed concentration: Mandatory individual label declaration above 10 ppm in leave-on products, 100 ppm in rinse-off products (EU 26 allergen list). IFRA 51st Amendment imposes stricter limits on linalool hydroperoxide content in formulations.. This is based on EU Regulation 1223/2009 and its amendments.
Linalool functions as: fragrance; skin-conditioning. It is classified as a Fragrance in our database. CAS number: 78-70-6.
The NOAEL (No Observed Adverse Effect Level) for Linalool is 1000 mg/kg bw/day based on a Developmental study via oral route in rat. Source: COSMOS DB.
Linalool also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Check Linalool compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Linalool in your formulation.